whitepaper

Whitepaper: Evaluating the impact of error rate on productivity and cost savings in synthetic DNA fragments

Posted: 16 September 2019 | | No comments yet

GeneArt High-Q Strings DNA Fragments versus other suppliers’ products.

Surveys and interviews with researchers revealed that less hands on time, an easy-to-use method and a high cloning success rate are important factors to consider to evaluate technologies and vendors for synthetic DNA. To address these needs, we developed Invitrogen™ GeneArt™ High-Q Strings™ DNA Fragments.

These DNA fragments are made using our cutting-edge microchip DNA synthesis platform, resulting in superior accuracy for uncloned DNA fragments. To demonstrate the benefits of this technology, we compared these GeneArt fragments to DNA fragments from two different suppliers and found that the GeneArt technology brings about a 60 percent reduction in cloning effort with up to 30 percent cost savings.











To read this Whitepaper in full, please complete the form below. By clicking submit you confirm that you accept our terms and conditions and privacy policy.


*

*

*

*

*

*

*

*

This content is provided to you for free thanks to the kind support of our sponsor: Thermo Fisher Scientific

Send this to a friend